Sherwin-Williams (SHW) PT Lowered to $423 at Jefferies

Jefferies analyst Laurence Alexander lowered the price target on Sherwin-Williams (NYSE: SHW) to $423.00 (from $439.00) while maintaining a Buy rating.

The analyst comments "We are trimming estimates for '25 to reflect a slightly higher interest expense assumption and for '26 to reflect mostly caution on the timing of a demand recovery. Consensus appears to be baking in more of a macro recovery in '25 and, in our view, will likely drift lower in the next couple of months. Shares appear to already discount this, and our models still support a >20% rally into the end of '25 assuming supportive Fed policy and no adverse policy shocks."

You May Also Be Interested In

• Stifel Starts Arrowhead Pharma (ARWR) at Buy
• Intuitive Surgical (ISRG) PT Lowered to $520 at TD Cowen
• Krystal Biotech (KRYS) PT Raised to $396 at BofA Securities